About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us

Hong Kong stocks opened higher and extended gains; Hang Seng up 1.00%, Hang Seng Tech up 1.43%. Innovative-drug names led the rally: China Biopharma (01177.HK) up >10%, Rongchang Biotech (09995.HK) up >7%, 3SBio (01530.HK) up >6%.

2026-07-06

Hong Kong stocks opened higher and extended gains; Hang Seng up 1.00%, Hang Seng Tech up 1.43%. Innovative-drug names led the rally: China Biopharma (01177.HK) up >10%, Rongchang Biotech (09995.HK) up >7%, 3SBio (01530.HK) up >6%.

Other News
2026-07-06

[Interbank Foreign Exchange Market Central Parity Rate for the Renminbi on July 6, 2026] USD/CNY was quoted at 6.8066, up 19 points (CNY depreciation); EUR/CNY was quoted at 7.7708, up 99 points; HKD/CNY was quoted at 0.86781, up 2.7 points; GBP/CN

[Interbank Foreign Exchange Market Central Parity Rate for the Renminbi on July 6, 2026] USD/CNY was quoted at 6.8066, up 19 points (CNY depreciation); EUR/CNY was quoted at 7.7708, up 99 points; HKD/CNY was quoted at 0.86781, up 2.7 points; GBP/CNY was quoted at 9.0705, up 105 points; AUD/CNY was quoted at 4.7120, up 156 points; CAD/CNY was quoted at 4.7825, down 32 points; 100 JPY/CNY was quoted at 4.2084, down 10 points; CNY/RUB was quoted at 11.3630, down 583 points; NZD/CNY was quoted at 3.8727, up 76 points; CNY/MYR was quoted at 0.59882, down 10.9 points; CHF/CNY was quoted at 8.4550, up 92 points; The Singapore dollar/Chinese yuan exchange rate was 5.2592, up 30 points.
2026-07-06

Asia's loan market showed no rebound entering H2, with APAC excluding Japan loan issuance in USD, EUR and JPY down 15% YoY to $69.0 billion in H1 — the weakest first half in 16 years. Bankers say spillovers from the Iran war have delayed investment a

Asia's loan market showed no rebound entering H2, with APAC excluding Japan loan issuance in USD, EUR and JPY down 15% YoY to $69.0 billion in H1 — the weakest first half in 16 years. Bankers say spillovers from the Iran war have delayed investment and deal activity and prompted tighter lender risk reviews, lengthening financing timelines. These headwinds could persist through the rest of the year, and competition may compress some loan spreads. BARCLAYS' head of Asia loan syndicate Andrew Ashman said: "With rising uncertainty, corporate confidence has weakened," adding that an expected M&A-driven pickup in loan volume has not materialised and geopolitical tensions may continue to affect future new loan activity.
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2026 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1905-1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.